Directory
>
Athena Countouriotis
Athena Countouriotis
Director Clinical Development | Capstan Therapeutics
California, San Diego, United States
Athena Countouriotis
Summary
Athena Countouriotis is a seasoned executive in the biopharmaceutical industry, currently serving as the Co-Founder and CEO of Avenzo Therapeutics. With an extensive background in clinical development, she has held leadership roles at several prominent companies including Ambit Biosciences and Turning Point Therapeutics. Athena's expertise spans across various aspects of clinical research and drug development, making her a key figure in advancing therapeutic innovations. She is also an active board member for multiple organizations, showcasing her commitment to fostering growth in the biotech sector. Athena holds a Doctor of Medicine degree from Tufts University School of Medicine, underscoring her strong academic foundation. Her career reflects a dedication to improving patient outcomes through innovative therapies. Outside of her professional endeavors, she is passionate about mentoring emerging leaders in the industry. Athena's diverse experience positions her as a thought leader in the evolving landscape of healthcare.
Athena Countouriotis
Work Experience
Board Member at
BioMarin Pharmaceutical Inc.
December 2023 - Present
Athena Countouriotis
Education
Tufts University School of Medicine, Doctor of Medicine - MD
Frequently Asked Questions about Athena Countouriotis
What is Athena Countouriotis email address?
Athena Countouriotis's primary email address is **************@halozyme.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Athena Countouriotis work for?
Athena Countouriotis is a Director Clinical Development at Capstan Therapeutics.
Where Athena Countouriotis graduated from?
Athena Countouriotis holds a degree in null from Tufts University School of Medicine.
How can I directly contact Athena Countouriotis?
To contact Athena Countouriotis directly, you can use the email address **************@halozyme.com. Complete contact information is available upon registration with Muraena.
Who is Athena Countouriotis?
Athena Countouriotis is a seasoned executive in the biopharmaceutical industry, currently serving as the Co-Founder and CEO of Avenzo Therapeutics. With an extensive background in clinical development, she has held leadership roles at several prominent companies including Ambit Biosciences and Turning Point Therapeutics. Athena's expertise spans across various aspects of clinical research and drug development, making her a key figure in advancing therapeutic innovations. She is also an active board member for multiple organizations, showcasing her commitment to fostering growth in the biotech sector. Athena holds a Doctor of Medicine degree from Tufts University School of Medicine, underscoring her strong academic foundation. Her career reflects a dedication to improving patient outcomes through innovative therapies. Outside of her professional endeavors, she is passionate about mentoring emerging leaders in the industry. Athena's diverse experience positions her as a thought leader in the evolving landscape of healthcare.
Athena`s contact details
**************@halozyme.com
**************@tptherapeutics.com
Colleagues
Sr. Manager, Human Resources
College Intern
Resident, Internal Medicine
Vice President, Research